Pneumonia (Pediatric) Clinical Trials

A listing of Pneumonia (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4

Subjects will be recruited and divided into 3 groups: Experimental Group (384 subjects): 1st dose : combined vaccination of COVIV+IIV4, 2nd dose: combined vaccination of COVIV+PPV23; Control Group A (384 subjects): 1st dose: COVIV only, 2nd dose: COVIV only; Control Group B (384 subjects): 1st dose: IIV4 only, 2nd dose: …

  • 0 views
  • 24 Mar, 2021
  • 3 locations
A Study to Determine the Efficacy Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) Versus Meropenem (MER) Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

A Phase 3 comparative study to determine the efficacy, safety and tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) versus Meropenem (MER) Colistin (COL) for the treatment of serious infections due to Gram negative bacteria.

colistin
antibiotic therapy
metronidazole
antibiotics
chest x-ray
  • 185 views
  • 01 Aug, 2021
  • 184 locations
Impact of Molecular Testing on Improved Diagnosis Treatment and Management of CAP

Investigators will recruit patients suspected of community-acquired pneumonia at Haukeland University Hospital, Bergen, into a pragmatic randomized controlled trial to assess if provision of ultra-rapid, high-quality accurate molecular diagnostics with direct feedback to the clinician can facilitate pathogen-directed usage of antibiotics, shorten antibiotic exposure and admission time and is safe. …

  • 0 views
  • 26 Jan, 2021
  • 1 location
Solar Oxygen Study

Globally, approximately 7.7 million children per year die before the age of 5 years. Infectious diseases account for a large proportion of these deaths, with pneumonia being the leading cause of mortality (2.1 million deaths/year). Most deaths occur in resource-poor settings in Asia and Africa. Oxygen (O2) therapy is essential …

  • 0 views
  • 27 Jan, 2021
  • 20 locations
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

This trial will evaluate whether empirical treatment against cytomegalovirus and tuberculosis improves survival of HIV-infected infants with severe pneumonia.

  • 0 views
  • 05 Mar, 2021
  • 13 locations
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients

Introduction- Hospital acquired infections (HAI) are a major cause of morbidity and mortality and increase health care costs. Critically ill patients are particularly susceptible to these infections and have an even higher mortality. One intervention that has gained much interest in the medical literature for reducing infection rates and deaths …

antibiotic therapy
nosocomial infections
critical illness
mechanical ventilation
antibiotics
  • 13 views
  • 28 Jan, 2021
  • 3 locations
Safety Tolerability and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients

To assess the safety, tolerability, and pharmacokinetics (PK) of cefiderocol after single-dose administration in hospitalized pediatric patients 3 months to < 12 years of age with suspected or confirmed aerobic Gram-negative bacterial infections and after multiple-dose administration in hospitalized pediatric patients 3 months to < 18 years of age with …

renal function
pneumonia
antibiotics
  • 2 views
  • 01 Aug, 2021
  • 20 locations
Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia

An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.

  • 0 views
  • 09 Apr, 2021
  • 1 location
Double-Blind Randomized Placebo-Controlled Adaptive Design Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

The study is a double-blind, randomized, placebo-controlled, adaptive design, multi-center, Phase 3 study to evaluate the efficacy and safety of fostamatinib in COVID-19 subjects.

respiratory failure
diagnostic procedures
covid-19
  • 0 views
  • 09 Jul, 2021
  • 43 locations
Transitional Care Model Evaluation 2020

The study is a randomized controlled trial to estimate the effects of the transitional care model (TCM) on hospital admissions and patients' experience during the year following the patient's qualifying discharge. The University of Pennsylvania, where TCM was developed, will be the coordinating center for the implementation. The study will …

heart failure
pneumonia
chronic obstructive pulmonary disease
copd exacerbation
COPD
  • 0 views
  • 25 Jan, 2021
  • 1 location